One hundred eighty patients undergoing ACL reconstruction (ACLR) were randomized to receive either 15 tablets (n=60), 25 tablets (n=58), or 35 tablets (n=62) of 5-mg oxycodone. The primary outcome of interest was postoperative pain control measured using the visual analog scale (VAS). Secondary outcomes included opioid consumption, patient satisfaction, and functional outcomes measured by International Knee Documentation Committee (IKDC) scores. Outcomes were assessed at intervals up to three months postoperatively. Overall, the results of the study revealed no significant difference in pain scores, opioid consumption, or patient satisfaction between groups. Prescribing fewer opioid tablets did not negatively impact pain management or satisfaction and may help reduce unused opioid doses.